T. Rowe Price Associates’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $1.22M | Buy |
|
|||||
|
2024
Q4 | $590K | Sell |
|
|||||
|
2024
Q3 | $560K | Buy |
|
|||||
|
2024
Q2 | $548K | Buy |
|
|||||
|
2024
Q1 | $474K | Buy |
|
|||||
|
2023
Q4 | $149K | Buy |
|
|||||
|
2023
Q3 | $122K | Buy |
|
|||||
|
2023
Q2 | $213K | Buy |
|
|||||
|
2023
Q1 | $218K | Buy |
|
|||||
|
2022
Q4 | $285K | Sell |
|
|||||
|
2022
Q3 | $3.43M | Sell |
|
|||||
|
2022
Q2 | $9.65M | Buy |
|
|||||
|
2022
Q1 | $8.64M | Sell |
|
|||||
|
2021
Q4 | $17.1M | Buy |
|
|||||
|
2021
Q3 | $19.4M | Sell |
|
|||||
|
2021
Q2 | $25.2M | Buy |
|
|||||
|
2021
Q1 | $19M | Buy |
|
|||||
|
2020
Q4 | $7.39M | Sell |
|
|||||
|
2020
Q3 | $29M | Sell |
|
|||||
|
2020
Q2 | $32.3M | Buy |
|
|||||
|
2020
Q1 | $29.2M | Buy |
|